Assessment of coagulation markers and decision curve analysis for predicting transfusions and hemostatic interventions in severe postpartum hemorrhage: A nationwide observational study in Japan
Thrombosis Research · 2026
DOI: 10.1016/j.thromres.2026.109686 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Thrombosis Research, 2026. Verfasst von Kamiyu Ii und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, Blood Transfusion, Hemostatics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Postpartum hemorrhage (PPH) remains a major cause of direct obstetric mortality. We aimed to predict pregnant women with severe PPH, defined as cases requiring hemostatic interventions-such as transcatheter arterial embolization, hysterectomy, bimanual uterine compression, or intrauterine balloon tamponade-or blood transfusions. METHODS: This retrospective observational study utilized a large-scale database covering approximately 600 hospitals in Japan from 2014 to 2023. Women of ≥18 years of age, emergency hospitalized for placental abruption, amniotic fluid embolism, or peripartum hemorrhage were included. Laboratory test (platelets, fibrinogen, fibrinogen/fibrin degradation product [FDP], and prothrombin time-internationalized ratio [PT-INR]) results at admission and perinatal parameters were collected. The primary outcome was receiving hemostatic intervention or blood transfusion. Risk factors were assessed by logistic regression and non-linear regression analyses. Decision curve analysis (DCA) was used to compare Japanese obstetric scores with platelet adjustment and three existing obstetric disseminated intravascular coagulation (DIC) scores. RESULTS: Among 902 obstetric inpatients meeting the inclusion criteria, 343 received hemostatic interventions or blood transfusions; 559 did not. Multivariate logistic regression revealed fibrinogen level (adjusted odds ratio [OR]: 0.994, 95% CI: 0.991-0.998), but not platelet count (adjusted OR: 0.980, 95% CI: 0.933-1.029) as a risk factor for the primary outcome. Non-linear regression using restricted cubic splines demonstrated that the predictive risk increased steeply when platelet count and fibrinogen fell below 10 × 104/μL and 200 mg/dL, respectively. DCA revealed that the platelet-adjusted obstetric DIC score developed in this study showed the highest net benefit across most threshold probabilities when compared with the pregnancy-modified ISTH DIC score, the JAAM-2 DIC score, and the new Japanese obstetric DIC score, although the advantage was modest. CONCLUSION: Platelet counts and fibrinogen levels may be useful for identifying women with severe PPH who are at risk of requiring hemostatic interventions and transfusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. Electronic address: ryo.hisamune@ompu.ac.jp.
- Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Department of Obstetrics and Gynecology, Mie University School of Medicine, Tsu, Japan.
- Department of Medical Statistics, Medical Research & Development Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Departments by Donation Obstetrics & Gynecology and Community Health, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Zitieren
APA
Ii, K., Hisamune, R., Ushio, N., Nii, M., Nishioka, D., Oda, T., Umemura, Y., Okamoto, K., Matsuoka, T., Mochizuki, K., Takasu, A., Yamakawa, K., & Japanese Society on Thrombosis and Hemostasis LOCOMOCO (Landmark Of Clinical Observations in MicrOcirculation and Coagulation Outcomes) study group (2026). Assessment of coagulation markers and decision curve analysis for predicting transfusions and hemostatic interventions in severe postpartum hemorrhage: A nationwide observational study in Japan. Thrombosis Research. https://doi.org/10.1016/j.thromres.2026.109686
Vancouver
Ii K, Hisamune R, Ushio N, Nii M, Nishioka D, Oda T, et al. Assessment of coagulation markers and decision curve analysis for predicting transfusions and hemostatic interventions in severe postpartum hemorrhage: A nationwide observational study in Japan. Thrombosis Research. 2026. doi:10.1016/j.thromres.2026.109686
BibTeX
@article{Ii2026,
author = {Ii, Kamiyu and Hisamune, Ryo and Ushio, Noritaka and Nii, Masafumi and Nishioka, Daisuke and Oda, Tomoaki and Umemura, Yutaka and Okamoto, Kohji and Matsuoka, Tadashi and Mochizuki, Katsunori and Takasu, Akira and Yamakawa, Kazuma and Japanese Society on Thrombosis and Hemostasis LOCOMOCO (Landmark Of Clinical Observations in MicrOcirculation and Coagulation Outcomes) study group, Japanese Society on Thrombosis and Hemostasis LOCOMOCO (Landmark Of Clinical Observations in MicrOcirculation and Coagulation Outcomes) study group},
title = {Assessment of coagulation markers and decision curve analysis for predicting transfusions and hemostatic interventions in severe postpartum hemorrhage: A nationwide observational study in Japan},
journal = {Thrombosis Research},
year = {2026},
doi = {10.1016/j.thromres.2026.109686}
}
EUVIMED